Preclinical evidence suggested that the conversion of the essential amino acid tryptophan (Trp) to immunoregulatory kynurenines (Kyn), generated by the enzymatic activity of IDO1, represents a key mechanism of immune escape within the tumor microenvironment (TME) (1, 2). This evidence concerns the gene IDO1 and neoplasm.